Anagenics Ltd has released a press release.
Rights Issue
Filed with ASX ·
On 6ix: 6ix.com/news/rights-issue-9
6ix hasn’t read this filing yet.
Earlier from Anagenics
- Cellmid Publishes Data on Novel Proprietary FGF5 Aptamer
- Cellmid Receives First Order From Chinese Distributor
- Cellmid Signs 10 Year Chinese Distribution Agreement
- Growth Strategy Presentation
- FY20 Financial Results
Later from Anagenics
- Rights Issue Prospectus
- Rights Issue Closed with Strong Demand
- Supplementary Prospectus
- Agreement Signed for Sale of Lyramid Limited
- Chinese Import Permits Received
Follow Anagenics into a list and get an email when it puts out news.
Follow Anagenics